AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 16
- Registration Number
- NCT00736788
- Locations
- 🇬🇧
Research Site, London, United Kingdom
A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 12
- Registration Number
- NCT00736606
- Locations
- 🇩🇪
Research Site, Berlin, Germany
An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2011-06-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 259
- Registration Number
- NCT00737009
- Locations
- 🇻🇳
Research Site, Hue, Vietnam
AZD1386 Japanese Multiple Ascending Dosing Study
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2009-09-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 32
- Registration Number
- NCT00736658
- Locations
- 🇯🇵
Research Site, Fukuoka, Japan
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 497
- Registration Number
- NCT00736879
- Locations
- 🇺🇸
Valley Research, Fresno, California, United States
🇺🇸Orange County Research Center, Tustin, California, United States
🇺🇸Endocrine Research Solutions, Inc., Roswell, Georgia, United States
Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199
Phase 2
Completed
- Conditions
- AsthmaAirway Obstruction
- Interventions
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 37
- Registration Number
- NCT00736489
- Locations
- 🇸🇪
Research Site, Lund, Sweden
Faslodex Registry: Fulvestrant in Current Clinical Practice
Completed
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2009-12-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 200
- Registration Number
- NCT00735215
- Locations
- 🇧🇪
Research Site, Wilrijk, Belgium
Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00733265
- Locations
- 🇺🇸
Research Site, San Antonio, Texas, United States
A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)
Phase 4
Completed
- Conditions
- Gastroesophageal Reflux Disease
- Interventions
- Procedure: Physical ExamOther: Quality of Life QuestionnairesProcedure: pregnancy test, if applicable
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2012-10-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 314
- Registration Number
- NCT00734097
- Locations
- 🇻🇪
Research Site, San Cristobal, Venezuela
Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
Phase 2
Completed
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00733668
- Locations
- 🇧🇪
Research Site, Sint-Truiden, Belgium
© Copyright 2025. All Rights Reserved by MedPath